Outcome assessment for clinical trials: How many adjudicators do we need?

Controlled Clinical Trials

Volumn 18, Issue 1, 1997, Pages 27-42

  Walter, S D ^a   Cook, Deborah J ^a   Guyatt, Gordon H ^a   King, Derek ^a   Troyan, Susan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

adjudication; analysis; clinical trials

Indexed keywords

ARTICLE; CLINICAL TRIAL; HUMAN; METHODOLOGY; TREATMENT OUTCOME;

CAUSE OF DEATH; COST-BENEFIT ANALYSIS; DECISION MAKING; DOCUMENTATION; FOLLOW-UP STUDIES; GUIDELINES; HUMANS; LUNG NEOPLASMS; MEDIASTINOSCOPY; MODELS, ORGANIZATIONAL; MULTICENTER STUDIES; OBSERVER VARIATION; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PROFESSIONAL STAFF COMMITTEES; RANDOMIZED CONTROLLED TRIALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031079743     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00131-6     Document Type: Article

References (7)

1. 1. Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6.
2. 2. Canner PL, Krol WF, Forman SA. External quality control programs. Controlled Clin Trials 1983;4:441-466.
3. 3. Sicurella J. The operation of a central adjudication committee and its effect on the validity of the assessment of treatment benefit. Society for Clinical Trials Meeting, Toronto, Ontario, May 7, 1990.
4. 4. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992;152:1490-1500.
5. 5. Curb JD, Babcock C, Pressel S, Tung B, Remington RD, Hawkins CM. Nosological coding of cause of death. Am J Epidem 1983;118:122-128.
6. 6. Burns BR, Comrie W, Willan AR, McCaughey WTE. Observer variation in the pathologic diagnosis of malignant lymphoma in Canada. Cancer 1988;62:314-318.
7. 7. Guyatt GH, Cook DJ, Walter SD, Ginsberg R, for The Canadian Lung Oncology Group. Investigation for mediastinal disease in patients with apparently operable lung cancer. Ann Thor Surg 1995;60:1382-1389.